Jeremy Adler, MD, MSc
Manage Your Profile
About
Jeremy Adler, M.D., M.Sc. is a Clinical Professor in the Division of Pediatric Gastroenterology at the University of Michigan and serves as research faculty in the Susan B. Meister Child Health Evaluation and Research (CHEAR) Center. Dr. Adler earned his M.D. degree at the University of South Florida College of Medicine. He completed his residency in pediatrics at Boston City Hospital and Boston Medical Center in 1997. He then practiced academic general pediatrics in New York for several years before moving to Michigan to train in pediatric gastroenterology at the University of Michigan. He then earned a Master of Science in Health and Health Care Research through in the Horace H. Rackham School of Graduate Studies at the University of Michigan, and had further training in the Advanced Improvement Methods program at Cincinnati Children’s Hospital. Dr. Adler joined the pediatric gastroenterology faculty at the University of Michigan in 2008.
Dr. Adler's clinical and research interest is in the care of children and adolescents with Crohn's disease and ulcerative colitis (inflammatory bowel disease or IBD). His research focus is on improving short and long-term outcomes and health related quality of life for children with IBD. He has been working on developing evidence-based strategies for preventing disease related complications such as fistulas and pouchitis, and to mitigate disparities among children with IBD.
Dr. Adler is an NIH-funded researcher whose scientific research has been featured in the American Gastroenterology Association's headline news, on the cover of the journal Inflammatory Bowel Diseases, and in the Innovations in Health Care section of the Wall Street Journal. Dr. Adler is a leader in the field of pediatric IBD, and has served as consultant to the US Food and Drug Administration, and his work on prevention of disease complications and on developing methods for evaluating endoscopic findings has been used in national and international policies and guidelines on treating children and adults with IBD. Dr. Adler also serves as the Director of Research and Quality Improvement in Pediatric Gastroenterology, and as the Director of the Pediatric IBD Program at C.S. Mott Children’s Hospital at Michigan Medicine.
Qualifications
-
Adaptive LeadershipUniversity of Michigan, United states
2024
Other
-
Linkage Leadership AcademyUniversity of Michigan, Ann Arbor, Michigan
2015 - 2015
Other
-
Advanced Improvement Methods (AIM), Center for Health Care QualityCincinnati Children's Hospital Medical Center, Cincinnati, Ohio
2012 - 2013
Other
-
Master of Science in Health and Health Care Research, Robert Wood Johnson Master's ProgramUniversity of Michigan Medical School, Ann Arbor, United States
2008 - 2009
Postdoctoral Research
-
Pediatric gastroenterology FellowshipC. S. Mott Children's Hospital, Ann Arbor, United States
2005 - 2008
Postdoctoral Research
-
Pediatric ResidencyBoston Medical Center, Boston, United States
1994 - 1997
Postdoctoral Research
-
MScHorace H. Rackham School of Graduate Studies, University of Michigan, Ann Arbor, MI, United States
2008 - 2009
-
MDUniversity of South Florida College of Medicine, 4202 E Fowler Ave, Tampa, FL, 33620, United States
1990 - 1994
-
BSUniversity of Florida, Gainesville, FL, United States
1986 - 1990
Center Memberships
-
Center MemberInstitute for Healthcare Policy and Innovation
Research Overview
Dr. Adler focuses on improving care of children and adolescents with Crohn's disease and ulcerative colitis. His research focus is on improving short and long-term outcomes and health related quality of life for children with IBD. He has been working on developing evidence-based strategies for preventing disease related complications such as fistulas and pouchitis, and to mitigate disparities among children with IBD.
Recent Publications
-
Samalik JM, Lee GJ, Modi ZJ, Adler J, ImproveCareNow IBD Learning Health System . J Pediatr Gastroenterol Nutr, 2026 Aug 3;Journal ArticleDisparities in child height at the time of inflammatory bowel disease diagnosis.
DOI:10.1002/jpn3.70524 PMID: 42548066 -
Van Hecke J, Veereman G, Huysentruyt K, Hauser B, Cools W, Cleymans NF, Adler J, Saeed S, De Greef E, ImproveCareNow Paediatric IBD Learning Health System . J Pediatr Gastroenterol Nutr, 2026 Jul 28;Journal ArticleThe ImproveCareNow Registry: Prediction of remission rates in paediatric Crohn's disease.
DOI:10.1002/jpn3.70519 PMID: 42520290 -
Constant BD, Feng Y, Huang J, Okraku-Mantey J, Adler J, Ali S, Barry J, Cruz R, Crawford EC, Dotson JL, Ewalt MK, Huang JS, Kachelries K, Kurowski JA, Minar P, Mitchel EB, Montminy TD, Morrow R, Pasternak B, Rabizadeh S, Sauer CG, Shapira T, Sunseri WM, Tarabishy I, Trombler B, Anupindi SA, Baldassano RN, de Zoeten EF, Scott FI, Albenberg L. Am J Gastroenterol, 2026 Jul 1;Journal ArticleThe Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in Children.
DOI:10.14309/ajg.0000000000004104 PMID: 42378115 -
Putzeys CC, Gautam N, Ritchey A, Kimberly A, Sharma U, Mirea L, Hamant L, Michel HK, Hilow E, Patel A, Ali S, Adler J, Moses J, Pasternak B. Crohn's & Colitis 360, 2026 Jun 25; otag034Journal ArticleRisk factors for Early-Onset Venous Thromboembolism in Pediatric Inflammatory Bowel Disease
DOI:10.1093/crocol/otag034 -
Caldera F, Hayney MS, Strople JA, Kastl AJ, Adler J, Boccieri M, Zhang X, Long MD, Kappelman MD. Am J Gastroenterol, 2026 May 20;Journal ArticleHigh Rates of Seroprotection for Measles in Pediatric Patients with Inflammatory Bowel Disease.
DOI:10.14309/ajg.0000000000004050 PMID: 42159717 -
Kuffa P, Adler J, Ostrowski MP, Pickard JM, Lo BC, Inohara N, Núñez G, Caruso R. Gastrointestinal Endoscopy, 2026 May 6; 103 (5): s - 900.Proceeding / Abstract / Poster824 SITE-SPECIFIC GENE-MICROBIAL INTERACTIONS IN CHILDREN WITH EARLY-ONSET CROHN’S DISEASE
DOI:10.1016/s0016-5107(26)02312-6 -
Kuffa P, Adler J, Ostrowski MP, Pickard JM, Lo BC, Inohara N, Núñez G, Caruso R. Gastroenterology, 2026 May 7; 170 (6): s - 900.Proceeding / Abstract / Poster824 SITE-SPECIFIC GENE-MICROBIAL INTERACTIONS IN CHILDREN WITH EARLY-ONSET CROHN’S DISEASE
DOI:10.1016/s0016-5085(26)02381-4 -
Gadepalli S, Tribble A, Rahman M, Manning L, Adler J. The Journal of Pediatrics, 2026 May 8; 115142 - 115142.Journal ArticleAntibiotic Utilization for Perianal Fistulizing Complications Among Young Patients with Crohn’s Disease
DOI:10.1016/j.jpeds.2026.115142
Featured News & Stories
Family that overcame Crohn’s supports research for future patients
Blake Hardin, MD/MPH student: Merging research and advocacy with medicine
Joanne Constantin, Postdoc: Bridging the fields of public health and medicine
Why anti-TNF drugs don’t work for some kids with Crohn's disease